<div><div dir="auto">Milton and I are willing to continue. </div></div><div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">On Mon, Mar 4, 2019 at 10:09 PM Rafik Dammak <<a href="mailto:rafik.dammak@gmail.com">rafik.dammak@gmail.com</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex"><div dir="auto"><div>Hi Kathy,<div dir="auto"><br></div><div dir="auto">Thanks,</div><div dir="auto">I think I clearly indicated that we are confirming with current members for their availability for phase 2. It is likely we will have to make replacement. It is not too early to prepare for the process.</div><div dir="auto"><br></div><div dir="auto">Best.</div></div></div><div dir="auto"><div><div dir="auto"><br></div><div dir="auto">Rafik </div><br><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">On Tue, Mar 5, 2019, 12:01 Kathy Kleiman <<a href="mailto:kathy@kathykleiman.com" target="_blank">kathy@kathykleiman.com</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">
<div text="#000000" bgcolor="#FFFFFF">
<p>Hi Rafik,</p>
<p>I think it would help to know how many of our incredible EPDP
Team are willing, ready and able to continue their back-breaking
work on the EPDP. If they are all ready to continue, I think we
would benefit from the continuity (and their incredible
sacrifice). In all events, before we put a call out for
replacements, it would be good to know how many places, if any, we
are filling.</p>
<p>Best,Kathy<br>
</p>
<div class="m_7122120065690920334m_4701408043604378615moz-cite-prefix">On 3/4/2019 6:17 PM, Rafik Dammak
wrote:<br>
</div>
<blockquote type="cite">
<div dir="ltr">Hi all,
<div><br>
</div>
<div>Keith communicated last week with all chairs of groups
represented in EPDP team to confirm or replace their members
there for phase 2. The same communication was shared with EPDP
team.</div>
<div><br>
</div>
<div>We are confirming with our NCSG representatives if they are
willing to continue for phase 2. We might need to do some
replacements and we have to act quickly in order for new
appointees to catch-up. It also depends on the expected
workload and that is ongoing discussion.</div>
<div><br>
</div>
<div>One way is to tweak the previous call for candidates and
send it asap in order to get a good pool of candidates from
where to select.</div>
<div>please let me know your thoughts and suggestions.</div>
<div><br>
</div>
<div>Best,</div>
<div><br>
</div>
<div>Rafik </div>
</div>
<br>
<fieldset class="m_7122120065690920334m_4701408043604378615mimeAttachmentHeader"></fieldset>
<pre class="m_7122120065690920334m_4701408043604378615moz-quote-pre">_______________________________________________
NCSG-PC mailing list
<a class="m_7122120065690920334m_4701408043604378615moz-txt-link-abbreviated" href="mailto:NCSG-PC@lists.ncsg.is" rel="noreferrer" target="_blank">NCSG-PC@lists.ncsg.is</a>
<a class="m_7122120065690920334m_4701408043604378615moz-txt-link-freetext" href="https://lists.ncsg.is/mailman/listinfo/ncsg-pc" rel="noreferrer" target="_blank">https://lists.ncsg.is/mailman/listinfo/ncsg-pc</a>
</pre>
</blockquote>
</div>
_______________________________________________<br>
NCSG-PC mailing list<br>
<a href="mailto:NCSG-PC@lists.ncsg.is" rel="noreferrer" target="_blank">NCSG-PC@lists.ncsg.is</a><br>
<a href="https://lists.ncsg.is/mailman/listinfo/ncsg-pc" rel="noreferrer noreferrer" target="_blank">https://lists.ncsg.is/mailman/listinfo/ncsg-pc</a><br>
</blockquote></div></div></div>
_______________________________________________<br>
NCSG-PC mailing list<br>
<a href="mailto:NCSG-PC@lists.ncsg.is" target="_blank">NCSG-PC@lists.ncsg.is</a><br>
<a href="https://lists.ncsg.is/mailman/listinfo/ncsg-pc" rel="noreferrer" target="_blank">https://lists.ncsg.is/mailman/listinfo/ncsg-pc</a><br>
</blockquote></div></div>-- <br><div dir="ltr" class="gmail_signature" data-smartmail="gmail_signature"><div dir="ltr"><div><font face="verdana, sans-serif">Farzaneh </font></div></div></div>